Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
national top stories
4
×
san francisco blog main
deals
fda
new york blog main
san francisco top stories
auris health
boston blog main
cancer
clinical trials
intuitive surgical
ipo
johnson & johnson
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roboticsai
san diego blog main
san diego top stories
startups
venture capital
abbvie
akouos
alex gorsky
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
armo biosciences
ashley mcevoy
aspire capital fund
astrazeneca
autoimmune
avalon ventures
biogen
What
plans
4
×
cash
company
deal
ipo
medical
acquiring
acquisitions
advance
announced
auris
billion
bio
biology
builds
buy
ceo
clearance
collabs
company’s
covid
crunch
cytokine
daniel
developer
didn’t
drugs
end
enhanced
fda
files
gilead
gilead’s
goal
health
help
initial
introduce
johnson
laying
Language
unset
Current search:
plans
×
biotech
×
" national top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs